SCHEMBL5229199

SCHEMBL5229199

O=S(=O)(Nc1cc(Cl)cc(Cl)c1)c1ccc(Br)s1

nearest known ligand 0.68

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.68
TP53 P04637 2/20 0.68
HTT P42858 8/20 0.62
SMN1; SMN2 Q16637 6/20 0.62
LMNA P02545 5/20 0.62
TSHR P16473 1/20 0.62
KMT2A Q03164 7/20 0.55
MEN1 O00255 6/20 0.55
MAPK1 P28482 3/20 0.55
PKM P14618 2/20 0.55
ALOX15 P16050 1/20 0.55
HSD17B10 Q99714 1/20 0.55
THRB P10828 2/20 0.51
ALDH1A1 P00352 3/20 0.50
HPGD P15428 2/20 0.50
NPSR1 Q6W5P4 1/20 0.48
KDM4E B2RXH2 1/20 0.48
SGK1 O00141 1/20 0.47
POLB P06746 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5230722 0.85 MAPT (0.69) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL26010796 0.78 LMNA (0.62) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5230311 0.77 PLAU (0.43) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5230476 0.77 FBP1 (0.44) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5228507 0.77 HTT (0.58) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5232052 0.76 TYMS (0.56) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL1346862 0.75 HTT (0.76) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5517767 0.73 HPGD (0.54) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL24254327 0.73 HPGD (0.58) MAPTTP53HTTSMN1; SMN2LMNA
SCHEMBL5231919 0.72 MEN1 (0.60) MAPTTP53HTTSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1519932-B1 BISARYLSULFONAMIDE COMPOUNDS AND THEIR USE IN CANCER THERAPY CYCLACEL LTD (GB) 2007-10-03 EP claimed